Vet Med - Czech, 2014, 59(11):553-572 | DOI: 10.17221/7820-VETMED

Effects of curcumin in combination with cyclophosphamide on canine mammary tumour cell linesOriginal Paper

F. Ustun Alkan1, C. Anlas1, S. Cinar2, F. Yildirim1, O. Ustuner1, T. Bakirel1, A. Gurel1
1 Faculty of Veterinary Medicine, Istanbul University, Istanbul, Turkey
2 Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey

In recent years, significant emphasis has been placed on combination chemotherapy in cancer using cytotoxic agents and plant derived-bioactive substances that are capable of selectively arresting cell growth and inducing apoptosis in tumour cells. The present study was undertaken to evaluate the possibility that the combination of curcumin and cyclophosphamide could show synergistic anti-proliferative effects towards CMT-U27 and CMT-U309 canine mammary cancer cells and, if so, to clarify the mechanism involved. The anti-proliferative activities of curcumin, cyclophosphamide and a combined treatment on CMT cells were determined using the MTT and LDH assays. The concentration of drug required for 50% inhibition of cell viability (IC50) and combination index (CI) values were calculated from log dose-response curves of fixed-combinations of curcumin and cyclophosphamide generated from MTT assays. Apoptosis was detected using a DNA fragmentation assay and Annexin-V/propidium iodide staining followed by flow cytometry. Cell cycle analyses were also performed using flow cytometry. The expression of the apoptosis-related proteins Bax and Bcl-2 was determined by immunocytochemical staining. MTT and LDH assays showed that curcumin and cyclophosphamide induced a dose- and a time-dependent decrease in cell viability. Isobole analysis revealed that the substances exhibited a synergistic interaction when IC50 and 1/2 IC50 concentrations of curcumin and cyclophosphamide were added concurrently to the cultures. This synergy was characterised by a significant increase in the percentage of early and late apoptotic CMT-U27 and CMT-U309 cells. However, internucleosomal fragmentation of DNA was not observed in the DNA fragmentation assay. Cells treated with curcumin and cyclophosphamide arrested at the G2/M and S phases of the cell cycle, respectively. In combined treatments cells were arrested in both phases of the cell cycle. Furthermore, immunocytochemical stainings demonstrated that the curcumin induced apoptosis in CMT cells by the modulation of Bcl-2/Bax protein expression, as the expression of Bcl-2 was decreased and that of Bax increased. This effect was more pronounced in combination treatments. In conclusion, our study shows that a combination of curcumin and cyclophosphamide shows synergistic growth inhibitory activity on CMT cells via induction of apoptosis and cell cycle arrest accompanied by modulation of Bcl-2/Bax protein expression. This finding provides a molecular basis for the development of natural compounds as novel anticancer agents and will allow lowering the dose of cytotoxic agents, which will in turn lead to more specific and less toxic therapies for mammary cancer in dogs.

Keywords: curcumin; cyclophosphamide; apoptosis; combination index; canine mammary cancer

Published: November 30, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ustun Alkan F, Anlas C, Cinar S, Yildirim F, Ustuner O, Bakirel T, Gurel A. Effects of curcumin in combination with cyclophosphamide on canine mammary tumour cell lines. Vet Med - Czech. 2014;59(11):553-572. doi: 10.17221/7820-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Al-Qubaisi M, Rozita R, Yeap SK, Omar AR, Ali AM, Alitheen NB (2011): Selective cytotoxicity of goniothalamin against hepatoblastoma Hep G2 cells. Molecules 16, 2944-2959. Anand P, Kunnumakkara AB, Newman RA, Aggarwal Go to original source... Go to PubMed...
    2. BB (2007): Bioavailability of curcumin: problems and promises. Molecular Pharmaceutics 4, 807-818. cell lines and Prof. Bulent Ekiz (Istanbul University, Atmaca H, Gorumlu G, Karac B, Degirmenci M, Tunali Go to original source... Go to PubMed...
    3. Turkey) for statistical analyses and Ataman Bilge Sari D, Cirak Y, Purcu Unuvar D, Uzunoglu S, Karabulut for preparation of the figures.
    4. B, Sanli UA, Uslu R (2009): Combined gossypol and zoledronic acid treatment results in synergistic induction of cell death and regulates angiongenic molecules in ovarian cancer cells. European Cytokine Network 10, 121-130. Go to original source... Go to PubMed...
    5. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Wu MS, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY (2001): Phase I clinical trial of curcumin, a chemopreventive agent, in patients with highrisk or pre-malignant lesions. Anticancer Research 21, 2895-2900.
    6. Chou TC, Talalay P (1984): Quantitative analysis of doseeffect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation 22, 27-55. Go to original source... Go to PubMed...
    7. Choudhuri T, Pal S, Agwarwal ML, Das T, Sa G (2002): Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. Febs Letters 512, 334-340. Go to original source... Go to PubMed...
    8. Choudhuri T, Pal S, Das T, Sa G (2005): Curcumin selectively induces apoptosis in deregulated Cyclin D1 expressed cells at G2 phase of cell cycle in a p53 dependent manner. Journal of Biological Chemistry 280, 20059- 20068. Go to original source... Go to PubMed...
    9. Cory S, Adams JM (2002): The Bcl2 family: regulators of the cellular life or death switch. Nature Reviews Cancer 2, 647-656. Go to original source... Go to PubMed...
    10. Cui J, Sun R, Yu Y, Gou S, Zhao G, Wang C (2010): Antiproliferative effect of resveratrol in pancreatic cancer cells. Phytotherapy Research 24, 1637-1644. Go to original source... Go to PubMed...
    11. Dhillon N, Aggarwal BB, Newman RA, Wolff RA, Kunnumakkara AB, Abbruzzese JL, Ng CS, Badmaev V, Kurzrock R (2008): Phase III trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research 14, 4491-4499. Go to original source... Go to PubMed...
    12. Dore M, Lanthier I, Sirois J (2003): Cyclooxygenase-2 expression in canine mammary tumors. Veterinary Pathology 40, 207-212. Go to original source... Go to PubMed...
    13. Egan B, Beilharz T, George R, Isenmann S, Gratzer S, Wattenberg B, Lithgow T (1999): Targeting of tail-anchored proteins to yeast mitochondria in vivo. FEBS Letters 451, 243-248. Go to original source... Go to PubMed...
    14. Elhawary SS, El Tantawy ME, Rabeh MA, Fawaz NE (2013): DNA fingerprinting, chemical composition, antitumor and antimicrobial activities of the essential oils and extractives of four Annona species from Egypt. Journal of Natural Sciences of Research 3, 59-68.
    15. Hirsch FR, Lippman SM (2005): Advances in the biology of lung cancer chemoprevention. Journal of Clinical Oncology 23, 3186-3197. Go to original source... Go to PubMed...
    16. Khar A, Ali AM, Pardhasaradhi BVV, Begum Z, Anjum R (1999): Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Letters 445, 165-168. Go to original source... Go to PubMed...
    17. Limtrakul P (2007): Curcumin as chemosensitizer. Advances in Expreimental Medicine and Biology 595, 269-300. Go to original source... Go to PubMed...
    18. Liu TY, Tan ZJ, Jiang L, Gu JF, Wu XS, Cao Y, Li ML, Wu KJ, Liu YB (2013): Curcumin induces apoptosis in gallbladder carcinoma cell line GBC-SD cells. Cancer Cell International 13, 1-9. Go to original source... Go to PubMed...
    19. Magalska A, Brzezinska A, Zmijewska AB, Piwocka GM, Sikora E (2006): Curcumin induces cell death without oligonucleosomal DNA fragmentation in quiescent and proliferating human CD8+ cells. Acta Biochimica Polonica 53, 531-538. Go to original source... Go to PubMed...
    20. Martin-Cordero C, Lopez-Lazaro M, Galvez M, Ayuso MJ (2003): Curcumin as a DNA topoisomerase II poison. Journal of Enzyme Inhibition and Medicinal Chemistry 18, 505-509. Go to original source... Go to PubMed...
    21. Menendez JA, del mar Barbacid M, Montero S, Sevilla E, Escrich E, Solanas M, Cortes-Funes H, Colomer R (2001): Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells. European Journal of Cancer 37, 402-413. Go to original source... Go to PubMed...
    22. Nautiyal J, Kanwar SS, Yu Y, Majumdar AP (2011): Combination of dasatinib and curcumin eliminates chemoresistant colon cancer cells. Journal of Molecular Signaling 6, 1-11. Go to original source... Go to PubMed...
    23. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N (2005): Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. Cancer Letters 224, 53-65. Go to original source... Go to PubMed...
    24. Priault M, Chaudhuri B, Clow A, Camougrand N, Manon S (1999): Investigation of bax-induced release of cytochrome c from yeast mitochondria permeability of mitochondrial membranes role of VDAC and ATP requirement. European Journal of Biochemistry 260, 684-691. Go to original source... Go to PubMed...
    25. Qian H, Yang Y, Wang X (2011): Curcumin enhanced adriamycin-induced human liver derived Hepatoma G2 cell death through activation of mitochondria mediated apoptosis and autophagy. European Journal of Pharmaceutical Sciences 43, 125-131. Go to original source... Go to PubMed...
    26. Ramachandran C, You W (1999): Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Research and Treatment 54, 269-278. Go to original source... Go to PubMed...
    27. Ravindran J, Prasad S, Aggarwal BB (2009): Curcumin and cancer cells: How many ways can curry kill tumor cells selectively? AAPS Journal 11, 495-510. Go to original source... Go to PubMed...
    28. Roy M, Chakraborty S, Siddiqi M, Bhattacharya RK (2002): Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pacific Journal of Cancer Prevention 3, 61-67.
    29. Sharma RA, Gescher AJ, Steward WP (2005): Curcumin: The story so far. European Journal of Cancer 41, 1955- 1968. Go to original source... Go to PubMed...
    30. Shishodia S, Singh T, Chaturvedi MM (2007): Modulation of transcription factors by curcumin. In: Aggarwal BB, Surh YJ, Shishodia S (eds.): The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease 595. Springer Publishing Company, New York. 127-148. Go to original source...
    31. Sikora E, Bielak-Zmijewska A, Magalska A, Piwocka K, Mosieniak G, Kalinowska M, Widlak P, Cymerman IA, Bujnicki JM (2006): Curcumin induces caspase-3-dependent apoptotic pathway inhibits DNA fragmentation factor 40/caspase-activated DNase endonuclease in human Jurkat cells. Molecular Cancer Therapeutics 5, 927-934. Go to original source... Go to PubMed...
    32. Simon D, Schoenrock D, Nolte I, Baumgartner W, Barron R, Mischke R (2009): Cytologic examination of fineneedle aspirates from mammary gland tumors in the dog: diagnostic accuracy with comparasion to histopathology and association with postoperative outcome. Veterinary Clinical Pathology 38, 521-528. Go to original source... Go to PubMed...
    33. Singh N, Nigam M, Ranjan V, Zaidi D, Garg VK, Sharma S, Chaturvedi R, Shankar R, Kumar S, Sharma R, Kalyan M, Balapure AK, Rath SK (2011): Resveratrol as an adjunct therapy in cyclophosphamide treated MCF-7 cells and breast tumor explants. Cancer Science 102, 1059-1067. Go to original source... Go to PubMed...
    34. Son YO, Lee KY, Kook SH, Lee JC, Kim JG, Jeon YM, Jang YS (2004): Selective effects of quercetin on the cell growth and antioxidant defense system in normal versus transformed mouse hepatic cell lines. European Journal of Pharmacology 502, 195-204. Go to original source... Go to PubMed...
    35. Sorenmo K (2003): Canine mammary gland tumors. Veterinary Clinics of North America: Small Animal Practice 33, 573-596. Go to original source... Go to PubMed...
    36. Sorenmo KU, Worley DR, Goldschmidt MH (2013): Tumors of the mammary gland. In: Withrow S, Vail D, Page R (eds.): Withrow and MacEwen's Small Animal Clinical Oncology. 5th ed. Elsevier Saunders, St. Louis. 538-556. Go to original source...
    37. ten Cate B, Samplonius DF, Bijma T, De Leij LFMH, Helfrich W, Bremer E (2007): The histone deacetylase inhibitor valproic acid potently augments gemtuzumab ozogamicin-induced apoptosis in acute myeloid leukemic cells. Leukemia 21, 248-252. Go to original source... Go to PubMed...
    38. Tyagi AK, Agarwal C, Chan DCF, Agarwal R (2004): Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDAMB468 cells. Oncology Reports 11, 2493-2499. Go to original source...
    39. van Engeland M, Nieland LJW, Ramaekers FCS, Schutte B, Reutelingsperger CPM (1998): Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31, 1-9. Go to original source... Go to PubMed...
    40. Walters DK, Muff R, Langsam B, Born W, Fuchs B (2008): Cytotoxic effects of curcumin on osteosarcoma cell lines. Investigationla New Drugs 26, 289-297. Go to original source... Go to PubMed...
    41. Widlak P, Palyvoda O, Kumala S, Garrard WT (2002): Modeling apoptotic chromatin condensation in normal cell nuclei Requirement for intranuclear mobility and actin involvement. Journal of Biological Chemistry 277, 21683-21690. Go to original source... Go to PubMed...
    42. Wu SH, Hang LW, Yang JS, Chen HY, Lin HY, Chiang JH, Lu CC, Yang JL, Lai TY, Ko YC, Chung JG (2010): Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade and mitochondria-dependent pathways. Anticancer Research 30, 2125-2133. Go to original source... Go to PubMed...
    43. Yang CW, Chang CL, Lee HC, Chi CW, Pan JP, Yang WC (2012): Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways. BMC Complementary and Alternative Medicine 12, 1-8. Go to original source... Go to PubMed...
    44. Yunos NM, Beale P, Yu JQ, Hug F (2011): Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells. Anticancer Research 31, 1131-1140.
    45. Zaidi D, Singh N, Ahmad IZ, Sharma R, Balapure AK (2011): Antiproliferative effects of curcumin plus Centchroman in MCF-7 and MDA MB-231 cells. International Journal of Pharmacy and Pharmaceutical Sciences 3, 212-216.
    46. Zheng M, Ekmekcioglu S, Walch ET, Tang CH, Grimm EA (2004): Inhibition of nuclear factor-κB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Research 14, 165-171. Go to original source... Go to PubMed...
    47. Zuccari DAPC, Santana AE, Cury PM, Cordeiro JA (2004): Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia. Veterinary Clinical Pathology 33, 23-28. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content